Evogene LTD. (EVGN) SEC Filings — 2025
18 SEC filings for Evogene LTD. (EVGN) in 2025.
Filings
- Evogene LTD. 6-K Filing — 6-K · Dec 30, 2025
- Evogene Ltd. Reports Q3 2025 Financial Results — 6-K · Nov 20, 2025
- Evogene Ltd. Files 6-K for H1 2025 Results — 6-K · Sep 30, 2025
- Evogene Ltd. Files September 2025 6-K Report — 6-K · Sep 10, 2025
- Evogene Ltd. Reports Q2 2025 Financial Results — 6-K · Aug 19, 2025
- Evogene Shareholders Approve All Proposals at Annual Meeting — 6-K · Aug 18, 2025
- Evogene Annual Meeting Adjourned Due to Lack of Quorum — 6-K · Aug 11, 2025
- Evogene Ltd. Files Proxy Card for August 11 AGM — 6-K · Jul 17, 2025
- Evogene's Lavie Bio Sells Most Operations to ICL — 6-K · Jul 8, 2025
- Evogene Ltd. Announces Annual Shareholder Meeting Date — 6-K · Jun 17, 2025
- Evogene Subsidiary Biomica CEO Steps Down Due to Medical Reasons — 6-K · Jun 5, 2025
- Evogene Ltd. Reports Q1 2025 Financial Results — 6-K · May 21, 2025
- Evogene Sells Lavie Bio Assets to ICL for $15.25M — 6-K · Apr 21, 2025
- Evogene Ltd. Files 20-F, Details 2024 Financials & Stock Split — 20-F · Mar 27, 2025
- Evogene Ltd. Board Chair Steps Down — 6-K · Mar 6, 2025
- Evogene Ltd. Shareholders Approve Key Proposal — 6-K · Feb 12, 2025
- Evogene Ltd. Meeting Adjourned Due to Lack of Quorum — 6-K · Feb 5, 2025
- Evogene Ltd. Announces Executive Departure Amid Restructuring — 6-K · Jan 15, 2025